Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Rivastigmine modifies the alpha-secretase pathway and potentially early Alzheimer's disease - Ray_2020_Transl.Psychiatry_10_47 |
| Author(s) : Ray B , Maloney B , Sambamurti K , Karnati HK , Nelson PT , Greig NH , Lahiri DK |
| Ref : Transl Psychiatry , 10 :47 , 2020 |
| Abstract : Ray_2020_Transl.Psychiatry_10_47 |
| ESTHER : Ray_2020_Transl.Psychiatry_10_47 |
| PubMedSearch : Ray_2020_Transl.Psychiatry_10_47 |
| PubMedID: 32066688 |
| Title : Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB - Nelson_2009_J.Alzheimers.Dis_16_29 |
| Author(s) : Nelson PT , Kryscio RJ , Abner EL , Schmitt FA , Jicha GA , Mendiondo MS , Cooper G , Smith CB , Markesbery WR |
| Ref : J Alzheimers Dis , 16 :29 , 2009 |
| Abstract : Nelson_2009_J.Alzheimers.Dis_16_29 |
| ESTHER : Nelson_2009_J.Alzheimers.Dis_16_29 |
| PubMedSearch : Nelson_2009_J.Alzheimers.Dis_16_29 |
| PubMedID: 19158418 |